Research from Osaka Metropolitan University in Japan indicates that while the amyloid-clearing drug lecanemab can reduce amyloid plaques associated with Alzheimer’s disease, it does not enhance...
Research conducted by scientists at Osaka Metropolitan University in Japan has revealed that lecanemab, a drug designed to eliminate amyloid plaques associated with Alzheimer’s disease, does...
